CYTOSPIRE
LIVE

Serial Number

79455621

Owner

Cytospire Therapeutics Limited

Filing Date

Jun 26, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CYTOSPIRE Trademark

Serial Number: 79455621

CYTOSPIRE is a trademark filed by Cytospire Therapeutics Limited on June 26, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Cytospire Therapeutics Limited

3rd Floor 1 Ashley Road

Entity Type: 98

Trademark Details

Filing Date

June 26, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the prevention and treatment of cancer and tumours; pharmaceutical preparations for the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; biological preparations for medical purposes; biological preparations for the prevention and treatment of cancer and tumours; biological preparations for use in the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; biological preparations for use in the prevention and treatment of cancer and tumours; biopharmaceuticals for the treatment of cancer; antibodies; diagnostic reagents for medical use.

Scientific and technological services; scientific research; pharmaceutical research and development services; medical research services; drug development services; laboratory analysis; laboratory research; laboratory testing; testing of pharmaceuticals; pharmaceutical research and development services in the field of oncology and immunotherapy; pharmaceutical research and development of pharmaceuticals and drugs for the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; medical research services in the field of oncology and immunotherapy; medical research services for the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; drug development services in the field of oncology and immunotherapy; drug development services for the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; laboratory research and testing of pharmaceuticals in the field of oncology and immunotherapy; laboratory research and testing of pharmaceuticals for the prevention and treatment of oncological disorders, immunological diseases and inflammatory diseases; research and development services in the field of antibodies; research and development in the field of biotechnology; development of antibodies; development of antibodies for use in the field of oncology and immunotherapy; information, consultancy and advice in relation to the aforesaid services.

Filing History

SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 6, 2026 REPR